Company / Shareholders' Equity
Revvity Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$7.3B
FY2025
5-year range
$7.1B / $7.9B
FY2021-FY2025
Trend
-5.4%
vs FY2024
Sector context
#23 of 161
Health Care
What the data says
Revvity's shareholders' equity of $7.3B is higher than 86% of companies in the Health Care sector (FY2025). Declined from $7.9B to $7.3B over the past 2 years.
Based on SEC 10-K filings.
$7.3B in FY2025 with a 5-year CAGR of +14.2%. Top quartile in the Health Care sector.
Declined from $7.9B to $7.3B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -0.6%
- 5-Year CAGR
- +14.2%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 161This company $7.3B Sector average $5.1B
▼
+43.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +14.2%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 5.4% year-over-year.
- Ranks #23 out of 161 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2023.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.3B | -5.4% |
| FY2024 | $7.7B | -2.6% |
| FY2023 | $7.9B | +6.6% |
| FY2022 | $7.4B | +3.4% |
| FY2021 | $7.1B | +91.2% |
| FY2020 | $3.7B | +32.8% |
| FY2019 | $2.8B | +8.9% |
| FY2018 | $2.6B | +3.3% |
| FY2017 | $2.5B | +16.2% |
| FY2016 | $2.2B | +2.0% |
As of FY2025 · SEC 10-K · Updated Mar 14, 2026